Clinical Trial Update: Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART-2) Trial - THE CHART-2 TRIAL [Phase 3]

View source ↗

Summary

Phase 3 trial CHART-2 is evaluating Cardiopoietic Regenerative Therapy for heart failure; the current status is listed as UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Cardiopoietic Regenerative Therapy

Snippet

Sponsor: Celyad Oncology SA | Conditions: Heart Failure | Phase 3 | Status: UNKNOWN